课题基金 / 基金详情

Determinants of Rod and Cone Response Characteristics

Determinants of Rod and Cone Response Characteristics
杆和锥响应特性的决定因素
批准号:
7455001
负责人:
JAMES Bryant HURLEY
金额:
$36.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 2011-06-30

项目摘要

项目成果

JAMES Bryant HURLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Phosphorylation of visual pigments is essential for normal vision. Deficiencies in this biochemical reaction can cause night blindness and photoreceptor apoptosis. Phosphorylation uncouples rhodopsin and most G-protein coupled receptors from downstream signaling pathways. The sites of phosphorylation on most G-protein coupled receptors are not known. During the previous funding period we developed a mass- spectrometry based method that enables us to determine the sites and kinetics of phosphorylation and dephosphorylation reactions that occur on visual pigments in intact retinas. We have used the method to establish the sites and kinetics of phosphorylation on mouse and zebrafish visual pigments under a variety of physiological conditions. We propose to use the method to pursue four new specific aims. 1. Evaluate rhodopsin phosphorylation during long-term illumination and identify relationships between visual pigment phosphorylation, visual cycle and visual sensitivity. 2. Evaluate factors that influence phosphorylation of cone visual pigments. 3. Identify structural characteristics that determine site selection and kinetics of phosphorylation by rhodopsin kinase. 4. Evaluate the influence of recoverin and Calcium on visual pigment phosphorylation. These studies will provide the most precise data yet available about the kinetics and site preferences for phosphorylation of G-protein coupled receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target
Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target
Respiration in vivo in the Retina and RPE
  • 批准号:
    10190455
  • 项目类别:
  • 资助金额:
    $26.48万
  • 财政年份:
    2021
  • 负责人:
    JAMES Bryant HURLEY
  • 依托单位:
Respiration in vivo in the Retina and RPE
  • 批准号:
    10390379
  • 项目类别:
  • 资助金额:
    $21.4万
  • 财政年份:
    2021
  • 负责人:
    JAMES Bryant HURLEY
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: